Connect with us

News

UAE Is Ready To Test New Face ID Technology In Service Delivery

Published

on

uae is ready to test new face id technology in service delivery
Shutterstock

It looks like UAE citizens won’t be required to identify themselves using government-issued documents in the near future. The country’s government has decided to greenlight an official trial of a new facial recognition technology (face ID technology) to further develop the services provided by the private and government sectors alike.

The decision was made at a Cabinet meeting on Sunday, which was chaired by His Highness Sheikh Mohammed bin Rashid Al Maktoum, Vice-President and Prime Minister of the UAE and the Ruler of Dubai. “In a meeting today, we have approved a facial recognition technology to verify the identity of individuals instead of submitting a lot of documents,” tweeted His Highness.

If the initial trial turns out successful, the ministry will expand the use of the facial recognition technology and support the launch of a related set of services in some private sector institutions.

Besides being convenient and efficient, citizen identification using face ID technology could also help curb the spread of the novel coronavirus and other infectious diseases. Similar contactless identification solutions are currently being deployed across airports, banks, and private businesses.

The Cabinet also approved the National Standards Manual for Statistical Data to provide a unified framework for the collection, processing, storage, and presentation of statistical data. The goal here is to ensure a high level of quality in all statistical activities, which play an essential role in supporting important governmental decisions.

Also Read: Dubai Police Use Futuristic Technology To Read Murder Suspect’s Mind

The manual covers eight basic topics: economic statistics, social and demographic statistics, education statistics, employment statistics, environment statistics, buildings and housing units statistics, and administrative divisions of each emirate.

It’s also worth mentioning that the Cabinet reviewed a study dealing with the prevention of mental and physical disabilities and reducing the mortality rate among children by performing premarital screenings for genetic diseases. According to the study, premarital genetic tests can reliably predict the risk of developing genetic diseases.

Advertisement

📢 Get Exclusive Monthly Articles, Updates & Tech Tips Right In Your Inbox!

JOIN 17K+ SUBSCRIBERS

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

News

Orchid Plans To Find Out What’s Wrong With You Before You’re Born

According to CEO Noor Siddiqui, the company isn’t on a mission to make designer babies, but aims to beat genetic odds and relieve suffering.

Published

on

startup orchid plans to find out what's wrong with you before you're born
Orchid

Each day, around 400,000 babies are welcomed into the world. However, among those, a growing number will experience some kind of birth defect or inherited disease.

Noor Siddiqui, CEO of Orchid, hopes to “mitigate” unpleasant genetic surprises using genome sequencing technology to reveal a wealth of genetic information on which newborns will grow into healthy adults.

Until 2019, IVF specialists had access to under 1% of the human genome. The tests, called PGT-A and PGT-M, scanned a mere 1,000 data points in a genome comprising around 3 billion bases, offering a very limited dataset compared to the technology used by Orchid.

“Our chromosomes are like chapters in a book that make up the table of contents.” Explained Siddiqui. “[PGT-A and PGT-M tests] only examine the table of contents, whereas what Orchid is doing is like a spellcheck on the entire book.” Orchid’s genome sampling technology assesses “100 times the data, covering many more conditions.” In essence, an Orchid report covers three categories of common genetic issues: monogenic disorders, polygenic conditions, and de-novo mutations.

Also Read: Advancing MENA Health Through AI Vascular Age Analysis

Orchid’s technology raises many questions. Aside from the obvious ethical concerns, data privacy is the most obvious potential issue with the tests. Noor Siddiqui is keen to alleviate any concerns: “No data at Orchid is ever sold to any third parties. Parents are in complete control of their data. If they want to delete the data, we’re happy to delete it off of our servers. If they want to export the data, they can export the data. And if they want us to re-analyze the data, we can re-analyze the data”.

Compared to a lifetime of medical bills, gene therapy, and suffering, Orchid’s genome screening report has the potential to change the future lives of thousands of newborns worldwide.

Continue Reading

#Trending